Age related side effects were not reported; interestingly, a trend for OS for the subgroup in patients over 70 years who received FLOT was observed, but this did not reach statistical significance ( p -value: 0.9402 HR: 0.723) [ 38 ].
← all excerpts
Considerations and Challenges in the Management of the Older Patients with Gastric Cancer.
1
—
—